| Appearance | White to Light yellow powder to crystal |
| Purity(HPLC) | min. 95.0 area% |
| Purity(Nonaqueous Titration) | min. 95.0 % |
| Melting point | 217.0 to 221.0 °C |
| NMR | confirm to structure |
Active Pharmaceutical Ingredients
Axitinib
(E)-N-Methyl-2-[[3-[2-(pyridin-2-yl)vinyl]-1H-indazol-6-yl]thio]benzamide; N-Methyl-2-[[3-[(1E)-2-(pyridin-2-yl)ethenyl]-1H-indazol-6-yl]sulfanyl]benzamide
| Purity / Analysis Method | >95.0%(T)(HPLC) |
| Molecular Formula / Molecular Weight | C22H18N4OS = 386.47 |
| Storage Temperature | 0-10°C |
| CAS RN | 319460-85-0 |
| Unit | Price |
| 50 mg | 4500 |
| 100 mg | 7250 |
| 1 g | 15750 |
| Note | •Pharmaceutical Ingredients (for Research and Experimental Use) is provided as delivered and specified by the issuing Pharmacopoeia. |
|---|
